Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 2Other hematologic neoplasm 1Myeloid 1Lymphoid 1CNS 1

Conditions

Brain Neoplasms 286Glioblastoma 259Glioma 202Neuroblastoma 86Neoplasms 61Astrocytoma 55Central Nervous System Neoplasms 53Medulloblastoma 46Breast Neoplasms 43Sarcoma 39Meningioma 39Melanoma 39Carcinoma, Non-Small-Cell Lung 39Neurofibromatosis 1 38Ependymoma 36Lung Neoplasms 35Osteosarcoma 31Rhabdomyosarcoma 30Sarcoma, Ewing 28Neoplasm Metastasis 28Diffuse Intrinsic Pontine Glioma 28Rhabdoid Tumor 27Recurrence 26Oligodendroglioma 23Wilms Tumor 21Gliosarcoma 21Pheochromocytoma 20Pancreatic Neoplasms 20Hepatoblastoma 20Thyroid Neoplasms 18

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
beta-Thalassemia × CNS × 90 days × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡